Occupational Exposure to Antineoplastic Drugs in Twelve French Health Care Setting: Biological Monitoring and Surface Contamination
Open Access
- 11 March 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (6) , 4952
Abstract
Antineoplastic drugs used in the treatment of cancers have an intrinsic toxicity, because of their genotoxic, teratogenic, and carcinogenic properties. Their use is recognized as an occupational hazard for healthcare workers (HCWs) who may be exposed. The purpose of this article is to present biological- and environmental-monitoring data collected in twelve French hospitals over eight years. Urine samples were collected from a wide range of HCWs (250 participants) from pharmacy and oncology units, including physicians, pharmacists, pharmacy technicians, nurses, auxiliary nurses, and cleaners. The investigated drugs were cyclophosphamide, ifosfamide, methotrexate, and α-fluoro-β-alanine, the main urinary metabolite of 5-fluorouracil. Wipe samples were collected from various locations in pharmacy and oncology units. More than 50% of participants, from all exposure groups, were contaminated with either drug, depending on the unit, the day, or the task performed. However, workers from oncology units were more frequently exposed than workers from pharmacy units. Significant contamination was detected on various surfaces in pharmacy and oncology units, highlighting potential sources of exposure. Risk-management measures should be implemented to reduce and maintain exposures at lowest-possible levels. In addition, regular exposure assessment, including biological and environmental monitoring, is recommended to ensure the long-term efficiency of the prevention measures.Keywords
This publication has 23 references indexed in Scilit:
- Antineoplastic Drug Contamination on the Hands of Employees Working Throughout the Hospital Medication SystemAnnals of Occupational Hygiene, 2014
- Environmental and Biological Monitoring of Platinum-Containing Drugs in Two Hospital Pharmacies Using Positive Air Pressure IsolatorsAnnals of Occupational Hygiene, 2012
- Occupational exposure to antineoplastic drugs in four Italian health care settingsToxicology Letters, 2012
- Occupational exposure to antineoplastic drugs in seven Italian hospitals: The effect of quality assurance and adherence to guidelinesJournal of Oncology Pharmacy Practice, 2010
- Multicenter study for environmental and biological monitoring of occupational exposure to cyclophosphamide in JapanJournal of Oncology Pharmacy Practice, 2010
- Biological Monitoring of Nurses Exposed to Doxorubicin and Epirubicin by a Validated Liquid Chromatography/Fluorescence Detection MethodAnnals of Occupational Hygiene, 2010
- Biological monitoring of occupational exposure to 5-fluorouracil: Urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnelJournal of Chromatography B, 2010
- Guidance Values for Surface Monitoring of Antineoplastic Drugs in German PharmaciesAnnals of Occupational Hygiene, 2009
- A probabilistic assessment of the impact of interventions on oncology nurses’ exposure to antineoplastic agentsOccupational and Environmental Medicine, 2006
- Exposure to Antineoplastic Drugs in Two UK Hospital Pharmacy UnitsAnnals of Occupational Hygiene, 2005